Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Related GILD
Gilead, Bank Of America, Costco: Fast Money Picks For September 28
15 Biggest Mid-Day Losers For Tuesday
Gilead's Corporate Culture: Fair Game For Commentators? (Seeking Alpha)
Related CELG
Early Clinical Data Released For Celgene's CELMoD
Mike Khouw Sees Unusual Options Activity In Celgene
Celgene's Trio Of New Drugs Could Tack On $3 Billion-Plus: RBC (Investor's Business Daily)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas


Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!